SCHEMBL19082117

SCHEMBL19082117

c1ccc2c(-c3c4ccccc4c(-c4ccc5c(c4)sc4c5ccc5sc6ccc7ccccc7c6c54)c4ccccc34)cccc2c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.37
CYP1A1 P04798 4/20 0.33
CYP1B1 Q16678 4/20 0.33
CYP1A2 P05177 2/20 0.33
NQO2 P16083 2/20 0.33
NQO1 P15559 1/20 0.33
LIMK1 P53667 2/20 0.32
SOS1 Q07889 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
MCL1 Q07820 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082375 0.97 ALOX5 (0.35) ALOX5CYP1A1CYP1B1CYP1A2NQO2
SCHEMBL19082237 0.95 ALOX5 (0.36) ALOX5CYP1A1CYP1B1CYP1A2NQO2
SCHEMBL19082359 0.94 ALOX5 (0.39) ALOX5CYP1A1CYP1B1CYP1A2NQO2
SCHEMBL19109098 0.92 ALOX5 (0.40) ALOX5CYP1A1CYP1B1CYP1A2NQO2
SCHEMBL17944586 0.92 ALOX5 (0.43) ALOX5CYP1A1CYP1B1CYP1A2NQO2
SCHEMBL17945665 0.92 ALOX5 (0.43) ALOX5CYP1A1CYP1B1CYP1A2NQO2
SCHEMBL19082185 0.91 CYP1A1 (0.34) ALOX5CYP1A1CYP1B1NQO2NQO1
SCHEMBL17944075 0.91 ALOX5 (0.42) ALOX5CYP1A1CYP1B1CYP1A2NQO2
SCHEMBL17945098 0.90 ALOX5 (0.40) ALOX5CYP1A1CYP1B1CYP1A2NQO2
SCHEMBL17945298 0.90 ALOX5 (0.40) ALOX5CYP1A1CYP1B1CYP1A2NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885CYP1A1 184/4885CYP1B1 260/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885CYP1A1 184/4885CYP1B1 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.